Washington Post Revelation of Pain Pill Distribution Only Helps to Fuel the False Narrative

Washington Post Revelation of Pain Pill Distribution Only Helps to Fuel the False Narrative

https://www.cato.org/blog/washington-post-revelation-pain-pill-distribution-only-helps-fuel-false-narrative

The Washington Post recently received access to a database maintained by the Drug Enforcement Administration that tracks the manufacture and distribution of every prescription opioid in the country. It reported that 76 billion pills were distributed throughout the US between 2006 and 2012, with higher volumes shipped to the areas that were most hard hit with opioid-related overdose deaths. 

This is being offered as proof that the overprescribing of prescription opioids caused the overdose crisis. But this flies in the face of other powerful evidence. Research reported in the Journal of Pain Research last February that examined data from the National Survey on Drug Use and Health as well as the Centers for Disease Control and Prevention show there is no correlation between the number of pain pill prescriptions and “past-month nonmedical use” or  past-year diagnosis of “pain reliever use disorder” among adults. This was corroborated by a study published by the Cato Institute the same month.

Research from the University of Pittsburgh shows overdose deaths from nonmedical use of licit and illicit drugs have been on a steady exponential increase since the 1970s, with no evidence of slowing. The only changes over the decades pertain to the particular drug in vogue during any period. In the early part of this century, the drugs in vogue were diverted prescription opioids. 

To be sure, the lure of easy money offered by a black market fueled by drug prohibition brings out the worst in people, and doctors and pharmacists were no exception. Some doctors and pharmacists leveraged their professional licenses and teamed up with regional drug dealers to supply nonmedical users with large quantities of their preferred drug. But the blame for such behavior should be placed where it belongs: drug prohibition.

Those unethical health care providers were the exception, not the rule. And they were providing drugs to mostly nonmedical users, sometimes under the guise of providing patient care. Meanwhile, the nonmedical use of prescription opioids peaked in 2012, as heroin became cheaper and more available than diverted pain pills. The prescription of high-dose opioids peaked in 2008 and the number dropped more than 58 percent by 2017. Yet the overdose rate accelerated as the prescription numbers decreased, because nonmedical users migrated to more readily available heroin and fentanyl. By 2015 there was already evidence that heroin was becoming the new drug in vogue, as up to one-third of heroin addicts undergoing rehab stated they initiated drug use with the opioid heroin.

The CDC released preliminary estimates of 2018 opioid-related overdose deaths July 17, and they suggest the death toll may be tapering off slightly, down to 47,590 from roughly 49,000 in 2017. One aspect of these numbers the media failed to report was that 67 percent of those deaths involved illicit fentanyl, one-third involved heroin, and just under one-third also involved cocaine. About one-fourth of opioid-related overdose deaths involved any prescription pain killer, and more than three quarters of them also involved heroin, fentanyl, cocaine, or tranquilizers. 

The overdose problem has never been a product of doctors treating patients for pain. It has always been a product of (a growing population of) nonmedical users accessing drugs in a dangerous black market fueled by drug prohibition. While the possible downturn or leveling off in the mortality rate is encouraging, this can largely be attributed to the adoption of harm reduction measures, such as naloxone distribution and needle-exchange programs, which need to be more widely-adopted.

The number of opioids prescribed greatly increased during the early part of this century, as doctors were–rightly–encouraged to be more concerned with alleviating pain and patients were–rightly–assured that opioids in the medical setting have a low overdose and addiction potential. That meant more pain pills were available for diversion to the black market for nonmedical use. And, as mentioned above, there were some doctors and pharmacists who were unethical and unscrupulous. But, at the end of the day, there is no correlation between the number of pills prescribed and the incidence of nonmedical use or use disorder.

The continued obsession about the number of pain pills being prescribed causes patients to go undertreated for their pain and will not make one IV drug user pull the needle out of their arm.

They are claiming that between 2006 and 2012 – SEVEN YEARS – 76 billion doses were dispensed at pharmacies.  That is about 11 billion/yr.  It is estimated that there is upwards of 35 million intractable chronic pain pts- those who need opiates 24/7.  Best practices and standard of care of these pts indicates that they should be prescribed 3 long acting and 4 short acting opiates per 24 hrs … or 2555 doses per year … and 35 million pts.. that comes to abt 89.5 BILLION doses/yr just for those with intractable chronic pain.  There is an estimated another 65 million chronic pain pt that can get by with a combination of a NSAID and two doses of a opiate/day that would be another 47.5 BILLION doses.

So if every chronic pain pt was properly treated – trying to get their average pain level < 5.. following best practices and standard of care – would require 137 billion doses in a SINGLE YEAR.  This does not account for any opiate doses prescribed to a pt dealing with acute pain – accident or surgery.

Just to make the math easy lets presume that all the acute pain issues would require another 15 billion…

so we are looking at an estimated ANNUAL number of opiate doses to be 152 billion to handle all the acute/chronic pain issues in the USA.  That 152 billion is TWICE what they claim was too many doses prescribe over a SEVEN YEAR PERIOD.

Let’s presume that my estimates are overly generous and cut the number IN HALF… showing a need for 76 billion doses… for A SINGLE YEAR …

That is ALMOST SEVEN TIMES the doses/yr that they claim were TOO MANY at 11 BILLION doses/yr. These numbers suggest that instead of opiate prescribing crisis … we have a denial of care of of adequate pain management for 6 out of 7 pts needing some sort of pain management with opiates.

Looking at this another way.. those people in need of pain management will only get abt 14% of the dose that would follow what is considered best practices and standard of care.

What other treatable/manageable disease does our society support/encourage the UNDER TREATMENT OF… specially when failure to properly treat will lead to other complication of their possible comorbidity health issues and/or DEMAND that they live/exist in a torturous level of pain ? 

Medical culture encourages doctors to avoid admitting mistakes

Medical culture encourages doctors to avoid admitting mistakes

www.statnews.com/2017/01/13/medical-errors-doctors/

If you become the victim of a medical error, should you trust your doctor to be forthright about his or her role in the mistake? That could be a bad idea. An alarming new study says that most doctors would try to obscure their role in the mistake, and most wouldn’t even apologize.

The study, conducted by a national team of researchers, posed two hypothetical scenarios involving medical error to more than 300 primary care physicians and asked how they would react. The first scenario involved a delayed diagnosis of breast cancer; the second involved a delayed response to a patient’s symptoms due to a breakdown in the coordination of the patient’s care. Most (more than 70 percent) of the physicians surveyed said they would provide “only a limited or no apology, limited or no explanation, and limited or no information about the cause.” The report was published last fall in the journal BMJ Quality and Safety.

The researchers noted that the strongest predictors of disclosure were “perceived personal responsibility, perceived seriousness of the event and perceived value of patient-centered communication.” In other words, doctors decide whether a mistake is a big enough deal to reveal to their injured patients.

In reality, the factor that most influences doctors to hide or disclose medical errors should be clear to anyone who has spent much time in the profession: The culture of medicine frowns on admitting mistakes, usually on the pretense of fear of malpractice lawsuits.

But what’s really at risk are doctors’ egos and the preservation of a system that lets physicians avoid accountability by ignoring problems or shifting blame to “the system” or any culprit other than themselves.

The lengths to which some doctors will go to shirk their responsibility to be upfront about medical errors are astounding. I consulted with one patient who experienced this kind of blame-shifting firsthand.

After what was supposed to be a routine spinal fusion procedure, Natalie (not her real name) awoke in extreme pain. The neurosurgeon put her on steroids for pain relief. Two days later, a different neurosurgeon discovered in post-operative imaging that the surgeon who performed the procedure had put a screw inside Natalie’s spinal canal — far from where it should have been and a tiny distance from damaging her spinal cord.

The original surgeon’s explanation? “The screw migrated.” Buffalo and geese migrate. Medical screws placed properly and carefully into bone do not.

As patients, we are conditioned to assume that our doctors know best and always have our best interests in mind. When they refuse to own their mistakes, they betray that trust and foster an environment in which patient safety takes a backseat to doctors’ reputations.

The end result is a medical culture in which errors cause 250,000 deaths per year in the United States alone, making it the third leading cause of death, behind heart disease and cancer, according to research published last year by Dr. Marty Makary, a Johns Hopkins surgeon and outspoken patient safety advocate, and research fellow Michael Daniel.

What is a patient to do in this environment? The first thing is to be aware of your own predisposition to take everything your doctor says at face value. Listen closely and you may hear cause for more intense questioning.

You will likely never hear the terms negligence, error, mistake, or injury in a hospital. Instead, these harsh but truthful words and phrases are replaced with softer ones like accident, adverse event, or unfortunate outcome. If you hear any of these euphemisms, ask more questions or seek another opinion from a different doctor, preferably at a different facility.

Most doctors would never tell a flagrant lie. But in my experience as a neurosurgeon and as an attorney, too many of them resort to half-truths and glaring omissions when it comes to errors. Beware of passive language like “the patient experienced bleeding” rather than “I made a bad cut”; attributing an error to random chance or a nameless, faceless system; or trivialization of the consequences of the error by claiming something was “a blessing in disguise.”

When a serious preventable medical error occurs, the physician who made it always has the option to do the right thing and fully disclose what happened. He or she can make an honest apology, which must include accepting responsibility for the error. He or she can also explain what options are available for compensation. Anything less is a pseudo-apology at best and a cover-up at worst.

Lawrence Schlachter, MD, is a board-certified physician, a medical malpractice attorney, and the author of “Malpractice: A Neurosurgeon Reveals How Our Health-Care System Puts Patients at Risk” (Skyhorse Publishing, January 2017).

Congressional candidate.. chronic pain advocate ?

As More States Legalize, DEA Chops Down Fewer Marijuana Plants, Federal Data Shows

As More States Legalize, DEA Chops Down Fewer Marijuana Plants, Federal Data Shows

www.marijuanamoment.net/as-more-states-legalize-dea-chops-down-fewer-marijuana-plants-federal-data-shows/

The Drug Enforcement Administration (DEA) seized far fewer marijuana plants in 2018 compared to the previous year but made significantly more cannabis-related arrests, according to federal data released this month.

More than 2.8 million indoor and outdoor marijuana plants were seized last year as part of the DEA’s Domestic Cannabis Eradication/Suppression Program. That marks a 17 percent decline from 2017 levels.

NORML first noted the DEA report, which also shows that marijuana-related arrests the agency was involved with increased by about 20 percent in a year. And while the overall number of plants that were seized dropped, DEA said that the value of the assets totaled about $52 million—more than twice as much as it reported the previous year.

State-level legalization efforts appear to have played a role in the declining number of plant seizures, particularly those cultivated outdoors. In the same year that retail cannabis sales started in California, DEA confiscated almost 40 percent fewer outdoor plants in the state compared to 2017.

That data point is consistent with recent research showing that legalization is associated with a decrease in the number of illicit cannabis grows in national forests, which are often targets for DEA enforcement action.

It’s not clear why there was a significant uptick in marijuana-related arrests, but those increases generally did not occur in states where legal cannabis systems were recently implemented.

For example, arrests in Kansas, where marijuana is strictly prohibited, increased by more than 3,500 percent—from 15 to 544—from 2017 to 2018. Louisiana likewise experienced a 168 percent increase in cannabis arrests.

The data covers federal law enforcement actions and does not include those of local police agencies that did not partner with the agency.

Year-over-year decreases in cannabis seizures through DEA’s eradication program have been viewed by advocates as evidence that state-level legalization systems effectively displace the illicit market, removing the incentive to illegally cultivate cannabis.

Similarly, a separate recent report from the U.S. Sentencing Commission showed that federal prosecutions for marijuana trafficking dropped precipitously in 2018—another sign demonstrating that state-level legalization is disrupting the illicit market, advocates argue.

NORML Deputy Director Paul Armentano told Marijuana Moment that “federal eradication programs are a holdover from a bygone era.”

“At a time when roughly one-quarter of the country resides in a jurisdiction where adult marijuana use is legal, and when members of Congress are openly discussing removing cannabis from the federal Controlled Substances Act, it is time for these federal anti-marijuana efforts to be put out to pasture and for federal agencies to take positions that more closely comport with cannabis’ rapidly changing cultural status in America,” he said.

DEA has also faced criticism of its cannabis eradication efforts from a non-partisan federal watchdog agency last year for failing to adequately collect documentation from state and local law enforcement partners funded through the program.

The Government Accountability Office said in a report that DEA “has not clearly documented all of its program goals or developed performance measures to assess progress toward those goals.”

At the same time that DEA is seizing fewer plants grown illicitly, it’s also setting higher goals for federally authorized cannabis cultivation for research purposes. In 2019, the agency said it hoped to grow approximately 5,400 pounds of marijuana to meet research demand, which is more than double its quota for 2018.

 

TN pain clinic: forcing patients to receive unnecessary injections into their back, then intentionally mislabeling the injections during billing

Four Tennessee pain clinics closing after arrests, fraud allegations

https://www.tennessean.com/story/news/health/2019/05/09/tennessee-pain-clinics-closing-painmd-rinova-fraud-allegations/1153043001/

Four Tennessee pain clinics have abruptly closed in the wake of federal authorities accusing executives and employees of inflating profits by giving patients thousands of worthless injections.

The clinics were formerly part of PainMD but were re-branded under the name Rinova after PainMD was accused of widespread fraud. The shuttered Rinova clinics are in Clarksville, Cookeville, Lawrenceburg and Tullahoma.

The clinics officially closed at the end of business on Wednesday. Some employees found out that same day the clinics were shutting down and they were losing their jobs. When contacted on Thursday morning, an employee said at least one clinic was minutes away from locking its doors for good.

Rinova is owned by Dr. Benjamin Johnson, a former PainMD executive who bought the four clinics in February when PainMD was quietly carved into thirds and sold off to company insiders. Johnson could not be reached for comment.

The abrupt closure of these clinics comes after months of escalating allegations against PainMD, which is headquartered in Franklin and at one point owned or managed as many as 30 pain clinics in Tennessee, North Carolina and Virginia. Both state and federal authorities have sued Pain MD alleging it committed health care fraud with bogus injections, and three PainMD nurse practitioners were criminally indicted for this same scheme last month. All three suspects have pleaded not guilty.

INVESTIGATION: Pain clinics, needles and greed: PainMD accused of injecting patients to meet profit quotas

It also appears that criminal investigation is climbing the company ladder. In the recent indictment, federal prosecutors also cast fraud allegations against the PainMD owner and chief medical officer, who are identified in court records by their job titles only. A separate, civil lawsuit related to the case identifies the owner of PainMD as Michael Kestner and the chief medical officer as Dr. Lisabeth Williams.

Over the past two weeks, the company has filed numerous court records under seal in an effort to hide the names of its leadership, arguing they would face “intense media scrutiny” and “damage to (their) personal and professional reputations” if they were identified as suspects in a criminal investigation.

Kestner and Williams have not been charged with any crime. U.S. Attorney Don Cochran has declined to say if they will face charges, but stressed that federal prosecutors have many ongoing investigations into medical practitioners.

PainMD’s attorney, Jay Bowen, did not immediately respond to a request for comment on Thursday.

The alleged PainMD scheme hinges on two pain-relieving injections that sound similar but are dramatically different when it comes to government reimbursement. The lawsuits say that PainMD staff gave patients “trigger point injections,” which government insurance programs will generally cover about four times a year, but intentionally mislabeled these injections as “tendon origin injections,” a more expensive procedure for which coverage is not capped. The result of the scheme, as alleged in court records, is that PainMD got rich, taxpayers got screwed and patients got jabbed with a needle over and over for no justifiable reason at all.

PAIN CLINICS: Feds to sue Sen. Steve Dickerson and other pain clinic owners over fraud, forgery allegations

Brett Kelman is the health care reporter for The Tennessean. He can be reached at 615-259-8287 or at brett.kelman@tennessean.com. Follow him on Twitter at @brettkelman.

Chronic pain pt asking LA of Senator Rubio to co-sponsor a bill reverse CDC guidelines

https://photos.google.com/share/AF1QipPTm3khV-Hxf1QEvt2QovbuHc-MAZqDbcc1PvplsMWeQ-TrxcFRPhaL8nMBuiXrfw/photo/AF1QipN8nTkbAwCxEvRG4hQQDPsfMyHfAhjfi4RIE1gW?key=V09VZTVVUk1lR0pmck5pMTFPQlVfcU8zUkpHaXdB

 

Click on link above to play video 

 

 

A Visitor from the Past

Class Action Lawsuit Slams UnitedHealthcare for Denying Drug Addiction Treatment While Millions of Americans Die from the Disease

UnitedHealthCare LawsuitClass Action Lawsuit Slams UnitedHealthcare for Denying Drug Addiction Treatment While Millions of Americans Die from the Disease

www.litigation-update.com/callahan-blaine-files-class-action-lawsuit-unitedhealthcare-opioid-addiction-treatment-denials/

SANTA ANA, CA–On average, 130 Americans die every day from an opioid overdose.

In 2017 alone, California lost 2,196 lives to the opioid epidemic.

Drug overdoses now cause more deaths than either car accidents or guns.

There is now a critical need for access to treatment for substance use disorders. Addiction is recognized as a chronic, relapsing brain disorder characterized by compulsive drug seeking, continued use despite harmful consequences, and long-lasting changes in the brain. Timely access to life-sustaining and life-saving treatment and continuing care for substance use and mental health disorders is critical to preventing unnecessary deaths, and allowing people to achieve long-term recovery and return to their families, friends and communities as healthy, productive and contributing members of society. Without treatment and engagement in recovery activities, addiction is progressive and can result in unemployment, homelessness, disability and premature death.

Ryan S. recognizes the necessity of timely access to treatment and continuing care for successful recovery, and he has experienced the demoralizing effect of insurance company exclusions and limitations on coverage. That is why on behalf of all persons who have suffered with substance use and mental health disorders and were denied treatment, Ryan is suing UnitedHealthcare for engaging in what he alleges to be an unlawful, institution-wide, pattern and practice of delaying, denying and underpaying claims for substance use disorder and mental health treatment despite the UnitedHealthcare plans specifically providing for benefits. The class action lawsuit in the United States District Court for the Central District of California, entitled Ryan S. v. UnitedHealth Group, Inc., et al., Case No. 8:19-cv-01363, was filed on July 11, 2019, by Ryan’s attorneys, Callahan & Blaine of Santa Ana, California.

The lawsuit describes seven company practices by UnitedHealthcare that Ryan’s lawyers allege were designed to deprive patients access to essential health care benefits in violation of a number of federal laws, including the Patient Protection and Affordable Care Act of 2010 (“PPACA”), 42 U.S.C. §§ 18001, et seq.; the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA), 42 U.S.C. § 300gg-26; and the Employee Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. §§ 1001 et seq. The plaintiffs are asking the court to order UnitedHealthcare to change its practices going forward in conformity with federal law, and to remedy the effects of its past wrongful conduct.

Traditionally, the lawsuit explains, insurers have covered treatment for mental health conditions, including substance use disorders, less favorably than treatment for physical health conditions, including higher cost-sharing obligations for patients, more restrictive limits on the number of inpatient days and outpatient visits, and more onerous prior authorization requirements. That was supposed to change with passage of the MHPAEA, but has not been the case as explained by Ryan Hampton, national addiction recovery advocate, author of American Fix, and opioid addiction survivor himself.

Ryan Hampton

“Parity violations aren’t the exception, they’re the rule in our country. For too long, big insurance companies – like United Healthcare – have gotten away with nothing short of murder. The name of their game is to deny basic medical care for substance use disorders at all costs – even if that cost is a human life. Over the past four years, I’ve lost over two dozen friends to preventable overdoses, people I loved and cared about. Many of them sought treatment multiple times, using their UnitedHealthcare PPO plans, only to be told their condition wasn’t medically necessary for treatment. Big insurance is playing Russian roulette with our lives. It’s time to hold them accountable. This lawsuit represents a massive step forward in raising the curtain on these deadly violations and starts to hold them accountable.”

Damon Eisenbrey of Callahan & Blaine, an expert on legal matters impacting the treatment industry, explained what’s at stake with this lawsuit. “Substance use disorder treatment is difficult and oftentimes involves cycles of recurrence and remission before long-term recovery is realized. We’re seeing insurance companies like UnitedHealthcare imposing access barriers at the patient’s initial request for treatment authorization. For those lucky and persistent enough to receive authorization, they face further exclusions and limitations on coverage that essentially deny the patient the treatment needed to recover. We intend to expose UnitedHealthcare’s objective to deny and limit coverage, in violation of industry standards and in pursuit of profits.”

Asked why he has sued the $150 billion insurance giant, Ryan S. stated, “I am alive today, clean and sober, because I was able to access the treatment I needed to fight my addiction. But I had to not only fight the demons of my addiction on my road to recovery, but also my insurance company, UnitedHealthcare. When an addict finally becomes willing to seek treatment, that window of opportunity is barely open and only for a moment. That window shouldn’t be slammed shut by insurance companies like UnitedHealthcare. I’m taking on this multi-billion dollar insurance company to tear down the barriers they’ve constructed to block patient access to treatment.”

Unfortunately for too many, there is no way to remedy the fatal effects of denied access to treatment. Jodi Barber, community advocate and Executive Producer of “Overtaken” and “Overtaken 2: Where Are They Now,” explains.

Jodi Barber

“As a mother who lost her 19-year-old son and three of his close friends in the same year, I know the importance and urgency of providing affordable, long-term treatment when someone with substance use disorder wants help. I receive calls every day from parents and from young adults desperate for help and it’s not available because of the high cost of insurance coverage or the fact that insurance won’t cover their treatment. Addiction is a brain disease and should be treated like any other disease. Deaths are occurring because of the lack of coverage.”

Leading health care attorney, Rich Collins of Callahan & Blaine, added that, “Despite the obvious public health interests, UnitedHealthcare is blatantly refusing to follow the law. And they’re doing it in the middle of an opioid epidemic! With this lawsuit, we intend to hold them responsible for their conscious disregard for the health and safety of its members like Ryan S. and for placing profits over patient care in a life and death situation.”

For more information, contact: Laurali Kobal, Firm Administrator, 714-241-4444, Laurali@callahan-law.com

ABOUT RICHARD T. COLLINS: Mr. Collins is known for being an aggressive trial attorney who has been named to the list of Super Lawyers each year since 2015. Rich has been lead counsel in over 25 jury and court trials in federal and state courts throughout California and elsewhere. He is a litigator with extensive experience in the areas of insurance recovery, coverage and bad faith, and has recovered millions of dollars for his policyholder and health care provider clients through verdicts and settlements. 714-241-4444, rcollins@callahan-law.com

ABOUT DAMON D. EISENBREY: Mr. Eisenbrey is a Senior Attorney at Callahan & Blaine.  He has extensive experience in complex business litigation involving unfair methods of competition and unfair and deceptive business acts or practices, and is regarded as an expert on legal matters affecting the substance use disorder treatment industry.  Mr. Eisenbrey also represents insurance policyholders and health care providers in individual and class action insurance recovery, coverage and bad faith matters, and he prosecutes and defends cases in state and federal court. 714-241-4444; deisenbrey@callahan-law.com.

ABOUT CALLAHAN & BLAINE: Founded in 1984, Callahan & Blaine is California’s Premier Litigation Firm with record-breaking verdicts and settlements in all areas of complex litigation. With a current roster of more than 28 trial lawyers experienced and focused in virtually all civil practice areas, Callahan & Blaine offers civil litigants an impressive set of credentials and client service values.  Our attorneys have more than 700 years of trial experience, and since 2003, our verdicts and settlements add up to over $1.0 billion. Our law firm represents consumers and corporate, professional and entrepreneurial clients of all sizes. https://www.callahan-law.com/

 

Surgeon General Backpedals on Flawed Tylenol Study. Because of ACSH

Surgeon General Backpedals on Flawed Tylenol Study. Because of ACSH.

https://www.acsh.org/news/2019/07/15/surgeon-general-backpedals-flawed-tylenol-study-because-acsh-14153

Fireworks can be an awful lot of fun on July 4th, but not so much if they blow up in your face. Unfortunately for Surgeon General Dr. Jerome Adams, his face was in the wrong place on Independence Day because of a ridiculous paper in a ridiculous journal called Emergency (Tehran). 

“Comparison of the Analgesic Effect of Intravenous Acetaminophen and Morphine Sulfate in Rib Fracture; a Randomized Double-Blind Clinical Trial” concludes that IV Tylenol works better (or as well) as morphine for patients who go to emergency departments for broken ribs – a notoriously painful injury. 

Here are Dr. Adams’ Tweets from July 3rd and 4th. Pay special attention to the one from July 4th on the right. Dr. Adams tells us that he unquestioningly believes the study results and offers no doubt about its accuracy.

It appears that Dr. Adams didn’t bother to read the paper from which this conclusion was drawn. So I did. And it was a colossal mess, something I explained on July 8th (See Need General Surgery? Ignore The Surgeon General). The study was so bad that it was impossible to tell whether Tylenol worked better than morphine, morphine worked better than Tylenol, or either drug worked at all.

A few days later ACSH friend, Dr. Aric Hausknect, a New York neurologist and pain management expert, who has both written for and been interviewed by us) must have read the paper as well because his July 12th letter made what I had to say seem rather tame by comparison (See Dr. Aric Hausknecht Responds To SG Jerome Adams’ Tylenol Recommendation).

Apparently, we hit the mark because in subsequent Tweets Dr. Adams was backpedaling like the bicycle scene from The Wizard of Oz played backward. Here are a few from July 13th…

Finally, there’s this…

What Dr. Adams did is no different than what PROP, certain members of the CDC, politicians, academic zealots, and various other self-serving individuals and groups have been doing for almost a decade –  making up a story and backing it up with faulty (or non-existent) research to “prove” a point. 

We just happened to catch him. 

(Illegal) fentanyl is now the leading cause of fatal drug overdoses claiming 49,000 lives in 2017

Chinese fentynal dealer busted by the DEA

https://foxsanantonio.com/news/local/chinese-fentynal-dealer-busted-by-the-dea

Chinese fentynal dealer busted by the DEA as he shipped thousands of dollars worth of fentynal into South Texas.

The DEA tells Fox San Antonio how the Chinese government help to bust the dealer in this week’s On the Frontlines with the DEA.

It’s a case that was years in the making, but now a major fentynal dealer from China has been taken down after the DEA identified him as the person shipping fentynal to Texas. The tiniest amount of this drug has proven to be deadly all over the country. In fact according to the DEA, fentanyl is now the leading cause of fatal drug overdoses claiming 49,000 lives in 2017. So when a man in China was identified shipping a kilo of fentynal into Texas the DEA was quick to move.

“At that time a parcel was seized of a bout a kilogram of what is known as molly MDMA. An investigation was done and what started as a kilogram turned into a lot more. We found out that this company was sending this product all over the country and actually all over the world,” said Dante Sorianello, the assistant special agent in charge of the San Antonio district.

The seller was in China and he would coordinate the movement of MDMA, steroids and fentynal all over the world including to a buyer right here in Texas.

“We found out that this lone individual had received over the past several years over 52 kg of MDMA that makes a lot of stimulant getting out on the streets and that’s just one individual,” said Sorianello.

But this case could not have been closed according to the DEA without the help of the Chinese government who help find a hidden lab in operating in China.

“Ultimately with our Chinese partners the Chinese government was able to identify that laboratory, seize it, dispose of the laboratory and arrest that individual,” said Sorianello.

Is it illegal to ship via. Is it illegal to ship via the us postal service and is it also illegal via a private company like UPS or Fedex?” Yami asked. “You’re dealing with a controlled substance, so yes it’s all illegal,” said Sorianello.

The DEA says that if you are caught shipping drugs via the us postal service vs a private company there are laws that allow them file more charges against you.

In your neighborhoods, on the streets, Fox San Antonio and the DEA will keep you informed and safe.